OptiNose
Yardley, US · Delaware corporation · 2 known investors
Healthtech
Founders & leadership
PD
Per DjupeslandExecutive Officer, Director
MJ
Michele JanisExecutive Officer
LP
Larry PickeringDirector
PO
Patrick O'NeillDirector
PM
Peter MillerExecutive Officer, Director
KD
Klaas De BoerDirector
TT
Terrence TerifayExecutive Officer
SV
Sriram VenkataramanDirector
WF
William F DoyleDirector
RM
Ramy MahmoudExecutive Officer
JP
Jackson PhillipsDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$4.7MraisedMay 2024 · 2 investors · PharmaceuticalsRule 506(b)
▶$4.7MraisedMay 2024 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Paul SpenceExecutive Officer
- Catherine E. OwenDirector
- Wilhelmus GroenhuysenDirector
- Eric BednarskiDirector
- Tomas J. HeymanDirector
- Sandra L. HeltonDirector
- Kyle DempseyDirector
- Ramy A. MahmoudDirector, Executive Officer
- Michael F. MarinoExecutive Officer
- R. John FletcherDirector
- Anthony J. KrickExecutive Officer
- Offering amount
- $4.7M
- Amount sold
- $4.7M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedNov 2021 · 2 investors · PharmaceuticalsRule 506(b)
▶$4MraisedNov 2021 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Peter K. MillerExecutive Officer, Director
- Michael F. MarinoExecutive Officer
- Wilhelmus GroenhuysenDirector
- Keith GoldanExecutive Officer
- Tomas J. HeymanDirector
- Catherine E. OwenDirector
- Ramy A. MahmoudExecutive Officer
- Victor M. ClavelliExecutive Officer
- Joseph C. ScodariDirector
- Sandra L. HeltonDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$250KraisedAug 2020 · 2 investors · PharmaceuticalsRule 506(b)
▶$250KraisedAug 2020 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Victor ClavelliExecutive Officer
- Joshua A. TamaroffDirector
- Michael F. MarinoExecutive Officer
- Sriram VenkataramanDirector
- William F. DoyleDirector
- Joseph C. ScodariDirector
- Ramy A. MahmoudExecutive Officer
- Robert P. O'NeilDirector
- Sandra L. HeltonDirector
- Keith GoldanExecutive Officer
- Wilhelmus GroenhuysenDirector
- Catherine E. OwenDirector
- Peter K. MillerExecutive Officer, Director
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.4MraisedSep 2019 · 2 investors · PharmaceuticalsRule 506(b)
▶$5.4MraisedSep 2019 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ramy A. MahmoudExecutive Officer
- Michael F. MarinoExecutive Officer
- Sriram VenkataramanDirector
- Robert P. O'NeilDirector
- Sandra L. HeltonDirector
- Wilhelmus GroenhuysenDirector
- William F. DoyleDirector
- Joseph C. ScodariDirector
- Keith GoldanExecutive Officer
- Peter K. MillerExecutive Officer, Director
- Joshua A. TamaroffDirector
- Offering amount
- $5.4M
- Amount sold
- $5.4M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$35MraisedApr 2017 · 8 investors · Other Health CareRule 506(b)
▶$35MraisedApr 2017 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joshua TamaroffDirector
- Patrick O'NeillDirector
- William F. DoyleDirector
- Ramy MahmoudExecutive Officer
- Keith GoldanExecutive Officer
- Peter MillerExecutive Officer, Director
- Michael MarinoExecutive Officer
- Klaas De BoerDirector
- Per DjupeslandDirector
- Larry PickeringDirector
- Tom GibbsExecutive Officer
- Sriram VenkataramanDirector
- Offering amount
- $35M
- Amount sold
- $35M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$35MraisedOct 2015 · 23 investors · Other Health CareRule 506(b)
▶$35MraisedOct 2015 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Per DjupeslandExecutive Officer, Director
- Michele JanisExecutive Officer
- Larry PickeringDirector
- Patrick O'NeillDirector
- Peter MillerExecutive Officer, Director
- Klaas De BoerDirector
- Terrence TerifayExecutive Officer
- Sriram VenkataramanDirector
- William F DoyleDirector
- Ramy MahmoudExecutive Officer
- Jackson PhillipsDirector
- Offering amount
- $35M
- Amount sold
- $35M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedOct 2015 · 21 investors · Other Health CareRule 506(b)
▶$15MraisedOct 2015 · 21 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Larry PickeringDirector
- Patrick O'NeillDirector
- Ramy MahmoudExecutive Officer
- Terrence TerifayExecutive Officer
- Peter MillerDirector, Executive Officer
- Jackson PhillipsDirector
- Sriram VenkataramanDirector
- William F. DoyleDirector
- Klaas De BoerDirector
- Per DjupeslandExecutive Officer, Director
- Michele JanisExecutive Officer
- Offering amount
- $30M
- Amount sold
- $15M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.